Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

In recent years, digital health has become a new development trend in the global health and medical industry. By using ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...

Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...

Charting, Price Performance, News & Related Contracts.

Must hold a qualification as a Credentialed Diabetes Educator with a minimum of 5 years’ credentialing and experience and holding a minimum of 4 years of diabetes technology clinical use , training ...

The target range is based on established medical standards, and most people fall between 70 ... pressed the button and popped the CGM right on. It happens fast and doesn't hurt at all. The monitor ...

A 10-year-old boy from New Town has been living life to the fullest despite his recent diagnosis of Type 1 diabetes.

Abbott Laboratories is showing strong growth potential with rising sales and EPS, though slightly overvalued. See why we are ...

The battle to improve the quadruple aim of care—reducing the cost of care, enhancing the experience of care, improving health ...

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

More and more people are talking abut the monitoring device, also known as CGM, for non-diabetics ... I prefer less medical intervention, and as little as possible for as long as I can get ...